Elemicin
Selleck Chemicals
SKU:S5120-25MG
Couldn't load pickup availability

Elemicin is an inhibitor of Dehydrogenases used in studies of Metabolic Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to metabolic regulation, energy sensing, and enzyme-linked homeostasis in metabolism models.
By inhibiting Dehydrogenases, Elemicin can be used to examine metabolic regulation, energy sensing, and enzyme-linked homeostasis. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Dehydrogenases
- Pathway perturbation studies connected to Metabolic Signaling
- Concentration-response inhibition and target-dependence studies
- Enzyme-activity assays, substrate-conversion studies, and mechanism profiling
Overall, Elemicin is appropriate when a defined chemical perturbant is needed to connect Dehydrogenases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Dehydrogenases
- Target Class:
- Enzyme
- Pathways:
- Metabolic Signaling
- Research Area:
- Metabolism
- CAS No.:
- 487-11-6
- Molecular Weight:
- 208.25
- Formula:
- C₁₂H₁₆O₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.